
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1021 | 1011 | 1073 | 1036 | 1013 | 1277 |
Fund Return | 2.07% | 1.11% | 7.31% | 1.17% | 0.25% | 2.47% |
Place in category | 315 | 183 | 182 | 187 | 188 | 57 |
% in Category | 54 | 36 | 32 | 56 | 79 | 56 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Swisscanto LU Bond Secured HiYld AT | 187.79M | 8.12 | 4.29 | 4.09 | ||
Swisscanto LU Bond Secured HiYld GT | 187.79M | 9.10 | 5.23 | 4.97 | ||
Swisscanto LU Bond Secured HiYld AA | 187.79M | 8.12 | 4.30 | 4.09 | ||
Swisscanto LU Bond GlblCnvrtble HBU | 138.7M | 2.61 | 1.46 | 3.57 | ||
SWBond Fund Global Convertible H US | 138.7M | 9.24 | -0.10 | 4.34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AvivaInvGlblInvGradeCorpBondIUSDAcc | 6.43B | 3.40 | -1.33 | - | ||
JPMorgan GlblCorpBond C dist USD | 6.07B | 1.59 | 1.90 | 2.60 | ||
JPMorgan Glbl Corp Bond C Acc USD | 6.07B | 1.59 | 1.90 | 2.60 | ||
JPMorgan Glbl Corp Bond I Acc USD | 6.07B | 1.60 | 1.94 | 2.64 | ||
LU1143726096 | 2.81B | 3.17 | -1.60 | 2.75 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SWC (LU) BF Resp. Crp Hybrid STH USD | LU2364759055 | 5.06 | - | - | |
Bank of America Corp. 6.204% | - | 1.41 | - | - | |
Citibank, N.A. 5.57% | - | 0.93 | - | - | |
UnitedHealth Group Inc. 5.875% | - | 0.92 | - | - | |
Takeda Pharmaceutical Co Ltd. 5.65% | - | 0.91 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review